Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challenges

Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challenges

IntroductionSurvival rates for early-stage non-small cell lung cancer (NSCLC) remain poor despite the decade-long established standard of surgical resection and systemic adjuvant therapy. Realizing this, researchers are exploring novel therapeutic targets and deploying neoadjuvant therapies to predi...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Sukumar Kalvapudi, Yeshwanth Vedire, Sai Yendamuri, Joseph Barbi
Formaat: Artikel
Taal:English
Gepubliceerd in: Frontiers Media S.A. 2023-12-01
Reeks:Frontiers in Oncology
Onderwerpen:
neoadjuvant
preoperative
NSCLC
systemic therapy
immunotherapy
chemoimmunotherapy
Online toegang:https://www.frontiersin.org/articles/10.3389/fonc.2023.1286104/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1286104/full

Gelijkaardige items